The DOI matches its Crossref record; 16 of the 18 references it cites were found in a registry or an index.
Thyrotropin Suppression by Thyroid Hormone Replacement is Correlated with Thyroxine Level Normalization in Central Hypothyroidism
Abstract
We have retrospectively studied 41 patients with hypothalamic-pituitary disease and central hypothyroidism associated with hypopituitarism. Sixteen patients had nonsecreting pituitary macroadenoma, whereas different sellar and suprasellar pathologies affected all other patients. Pretreatment thyrotropin (TSH) level (mean +/- standard error of the mean [SEM]) was 2.04 +/- 0.25 mU/L (normal, 0.4-4), and gradually decreased to 0.51 +/- 0.19 mU/L (range, 0.009-3.38) by treatment with levothyroxine in a mean dose of 86 +/- 6 microg/d. TSH was suppressed by thyroid replacement to less than 0.5 mU/L in 80% of patients. Mean baseline free thyroxine (FT4) was 7.55 +/- 0.51 pmol/L (normal, 11.8-24.6) and gradually increased with thyroid hormone to 15.19 +/- 1.0 pmol/L, whereas total thyroxine (TT4) increased from 57.4 +/- 2.6 to 104.4 +/- 5.0 nmol/L (normal, 77-154). Mean pretreatment total triiodothyronine (TT3) was 1.44 +/- 0.09 nmol/L (normal, 1.1-2.7), and was not altered by treatment. Thyrotropin-releasing hormone (TRH) test was performed in 20 patients before thyroid replacement, and mean baseline and peak TSH levels were 1.33 +/- 0.3 and 7.14 +/- 1.62 mU/L, respectively. In 5 subjects TSH was stimulated to 6 mU/L or more, whereas in 5 others TSH was not affected. Based on linear regression of logarithm (Ln) TSH against FT4, a leftward shift of the TSH/FT4 ratio was demonstrated in patients with central hypothyroidism compared to 17 patients with primary hypothyroidism. Plotting…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A couple of groups also reported that low TSH values are more likely to be associated with adequate replacement in CeH patients [61, 62].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [62]
In the citing paper
“Many patients with CH have undetectable TSH levels on presentation, and almost all CH patients adequately treated with L-T4 to maintain serum fT4 levels in the mid-to high-normal range will have undetectable TSH levels (75,80,127,129).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [129]
In the citing paper
“Even low doses of L-T4 are able to suppress TSH secretion (42, 59).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [59]
Citations
Cites
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
FAGLIA, G., BITENSKY, L., PINCHERA, A., FERRARI, C., PARACCHI, A., BECK-PECCOZ, P., AMBROSI, B., & SPADA, A. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-989 · Cited by 197 · cited 1×
“Decreased bioactivity of circulating TSH is a common alteration in patients with hypothalamic-pituitary lesions and central hypothyroidism (12,13) contributing, along with the impairment of pituitary TSH secretion, to the pathogenesis of low thyrotropic activity in these patients.”
Larsen, P. R., Dick, T. E., Markovitz, B. P., Kaplan, M. M., & Gard, T. G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109430 · Cited by 149
Ferretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., & Beck-Peccoz, P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5553 · Cited by 134
Maturation of Human Hypothalamic-Pituitary-Thyroid Function and Control
Fisher, D. A., Nelson, J. C., Carlton, E., & Wilcox, R. B. (2000) · Thyroid · doi:10.1089/thy.2000.10.229 · Cited by 129
The Hypothyroxinemia of Prematurity
de Escobar, G. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4587-3 · Cited by 74
Circulating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism
Persani, L. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3631 · Cited by 70 · cited 1×
“Decreased bioactivity of circulating TSH is a common alteration in patients with hypothalamic-pituitary lesions and central hypothyroidism (12,13) contributing, along with the impairment of pituitary TSH secretion, to the pathogenesis of low thyrotropic activity in these patients.”
Gordon, M. B., & Gordon, M. S. (1999) · Endocrine Practice · doi:10.4158/ep.5.5.233 · Cited by 67
Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test
Wardle, C. A., Fraser, W. D., & Squire, C. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04248-3 · Cited by 67 · cited 1×
“In the absence of specific clinical signs in central hypothyroidism (11) and reliable peripheral indexes, either clinical or biochemical, of thyroid hormone action (2), monitoring TSH levels during thyroid replacement, together with FT 4 , may serve as a comprehensive hormonal follow-up.”
Thyroid Function in Premature Infants: The Hypothyroxinemia of Prematurity
Fisher, D. A. (1998) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)31344-7 · Cited by 61
Research works printed but not linked: 1
- Bakiri F, 1999, Ann Endocrinol (Paris), 60, 422
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“The other retrospective studies show varying findings (396, 397).”
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Jostel, A., Ryder, W. D. J., & Shalet, S. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03534.x · Cited by 238
Metadata
- Authors
- Shimon, I., Cohen, O., Lubetsky, A., & Olchovsky, D.
- Affiliations
- Sheba Medical Center (IL)
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2002-09
- Volume
- 12
- Issue
- 9
- Pages
- 823-827
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1486818631
- Semantic Scholar
- 4f50b2d5a7118823b880c4c150858b0327b490fc
- Cited by
- 72
- References
- 18
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 2 · 2016: 7 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- central hypothyroidism, TSH suppression, levothyroxine, thyroid hormone replacement, hypothalamic-pituitary disease, hypopituitarism, pituitary macroadenoma, free thyroxine, triiodothyronine, primary hypothyroidism, TSH-secreting pituitary adenoma
- MeSH terms
- Adolescent, Adult, Aged, Feedback, Female, Follow-Up Studies, Humans, Hypothyroidism, Male, Middle Aged, Retrospective Studies, Thyrotropin, Thyroxine, Triiodothyronine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyrotropin Suppression by Thyroid Hormone Replacement is Correlated with Thyroxine Level Normalization in Central Hypothyroidism. https://app.cochat.ai/papers/10.1089/105072502760339406
- The paper
- Shimon, I., Cohen, O., Lubetsky, A., & Olchovsky, D. (2002). Thyrotropin Suppression by Thyroid Hormone Replacement is Correlated with Thyroxine Level Normalization in Central Hypothyroidism. Thyroid. https://doi.org/10.1089/105072502760339406
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.